![The F-35’s future: The world’s most advanced stealth fighter and what comes next [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/03/8477353.jpg?#)
Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug
Pathos AI has secured $365 million in series D funds as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics.
Pathos AI has secured $365 million in series D funds as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics.
